A new initiative called the Movement Health Foundation (MHF) has been launched with a pledge to encourage greater use of digital technologies to equalise access to healthc
Roche has made its case for BTK inhibitor fenebrutinib as a potential new oral therapy for multiple sclerosis, with a phase 2 readout that it says shows significant improv
Swiss pharma Roche has today officially launched a new institute that will focus on the use of human model systems – in vitro replicas of human tissues and organs – for dr
